Alzheimer’s APOE4 Genetic Risk Targeted in Promising Trialnews2022-12-02T21:55:07+00:00December 2nd, 2022|The New York Times|
The Disease Took Zara, Then Sara. Could Ayla Be Saved?news2022-11-09T22:00:17+00:00November 9th, 2022|The New York Times|
Gene Treatment for Rare Epilepsy Causes Brain Side Effect in 2 Childrennews2022-10-26T18:19:16+00:00October 26th, 2022|The New York Times|
Hospital and Drugmaker Move to Build Vast Database of New Yorkers’ DNAnews2022-08-12T09:00:15+00:00August 12th, 2022|The New York Times|
The Quest by Circadian Medicine to Make the Most of Our Body Clocksnews2022-07-06T09:00:24+00:00July 6th, 2022|The New York Times|
Targeting the Uneven Burden of Kidney Disease on Black Americansnews2022-05-17T07:01:35+00:00May 17th, 2022|The New York Times|
Family in Nigeria Lost 3 Daughters to Sickle Cell. Can They Save a Fourth?news2021-12-21T12:27:49+00:00December 21st, 2021|The New York Times|
Cancer Without Chemotherapy: ‘A Totally Different World’news2021-09-27T15:12:03+00:00September 27th, 2021|The New York Times|
What Is 23andMe Doing With Your DNA?news2021-09-20T18:12:06+00:00September 20th, 2021|The New York Times|
